It might not be a year-end rally,...

It might not be a year-end rally, but there are buyers out there for some stocks, according to Irving Katz, director of research for Thomas Green/San Diego Securities. Despite the rebound in the market in general, only two San Diego stocks managed to move more than a point in the past week, Katz said.

Molecular Biosystems made a sharp run up to a new high of $17 and closed the week with a $3.50 gain, to $16.25. The company signed a contract worth up to $60 million with the Mallinckrodt division of International Minerals & Chemical for exclusive North and South American marketing and distribution rights for Albunex, a nontoxic contrast agent used for ultrasound imaging of the heart and other internal organs.

Agouron Pharmaceuticals recorded a new high of $17 and closed the week up $1. The company held its annual meeting last week.

The only other new high was made by PSICOR Inc., which reached $8 and closed up $.25, at $7.75.

Three new stocks, all traded over-the-counter, have been added to The Times’ quotation chart this week: General Microelectronics, Medi-Mail and Yuba Natural Resources.

On the downside was San Diego Gas & Electric, which dropped $.875. SDG&E; and SCEcorp on Monday completed merger filings with the Federal Energy Regulatory Commission and the California Public Utilities Commission. Local opposition to the merger continues to mount, Katz said.

Henley Group dropped $.625, to $21.875, after a scathing article Monday in Barron’s magazine about alleged self-dealing by Henley’s top management. Burnham Pacific Properties was down $.375 as it filed a registration statement in connection with a 1.5-million-share stock offering in January.

Wavetek was down $.25, to $5.25, after announcing a loss of $7.6 million, or $.86 a share.

Cubic Corp. was off $.125 despite announcing fourth-quarter earnings of $.59 a share and fiscal-year earnings of $1.70 a share.